Show items per page
Elements: 106
Page 1 on 3
 TitleAuthors / EditorsDate
add to browser selection
A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort Study Yerly Ferrillo, Sabine; Perneger, T. V.; Hirschel, Bernard; Dubuis, O.; ... Perrin, Luc 1998
add to browser selection
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection Fagard, Catherine; Oxenius, Annette; Gunthard, Huldrych; Garcia, Felipe; ... Hirschel, Bernard 2003
add to browser selection
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection Opravil, Milos; Hirschel, Bernard; Lazzarin, Adriano; Furrer, Hansjakob; ... Perrin, Luc 2002
add to browser selection
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study Bernasconi, Enos; Boubaker, Karim; Junghans, Cornelia; Flepp, Markus; ... Telenti, Amalio 2002
add to browser selection
Adherence as a Predictor of the Development of Class-Specific Resistance Mutations: The Swiss HIV Cohort Study von Wyl, Viktor; Klimkait, Thomas; Yerly Ferrillo, Sabine; Nicca, Dunja; ... Glass, Tracy R 2013
add to browser selection
Adverse events of raltegravir and dolutegravir Elzi, Luigia; Erb, Stefan; Furrer, Hansjakob; Cavassini, Matthias; ... Battegay, Manuel 2017
add to browser selection
Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification Keiser, Olivia; Fellay, Jacques; Opravil, Milos; Hirsch, H. H.; ... Furrer, Hansjakob 2007
add to browser selection
AIDS defining opportunistic infections in patients with high CD4 counts in the combination antiretroviral therapy (cART) era: things ain't what they used to be Gisler, Valentin; Kraus, David; Nemeth, Johannes; Lecompte, Marthe Than; ... Furrer, Hansjakob 2014
add to browser selection
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study Ledergerber, Bruno; Egger, M.; Erard, V.; Weber, R.; ... Telenti, A. 1999
add to browser selection
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012 Yang, Wan-Lin; Kouyos, Roger; Scherrer, Alexandra U; Böni, Jürg; ... Günthard, Huldrych F 2015
add to browser selection
Assessment of a real-time PCR test to diagnose syphilis from diverse biological samples Gayet-Ageron, Angèle; Bescher Ninet, Béatrice Alice; Toutous-Trellu, L.; Lautenschlager, S.; ... Hirschel, Bernard 2009
add to browser selection
Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study Young, Jim; Rickenbach, Martin; Weber, Rainer; Furrer, Hansjakob; ... Bucher, H. C. 2005
add to browser selection
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study Kaufmann, G. R.; Perrin, Luc; Pantaleo, Guiseppe; Opravil, Milos; ... Battegay, Manuel 2003
add to browser selection
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy Khanna, Nina; Opravil, Milos; Furrer, Hansjakob; Cavassini, Matthias; ... Kaufmann, Gilbert R. 2008
add to browser selection
CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy Wolbers, Marcel; Battegay, Manuel; Hirschel, Bernard; Furrer, Hansjakob; ... Bucher, H. C. 2007
add to browser selection
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial Ananworanich, Jintanat; Gayet-Ageron, Angèle; Le Braz, Michelle; Prasithsirikul, Wisit; ... Hirschel, Bernard 2006
add to browser selection
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy Rohrbach, Janine; Robinson, Nicola; Harcourt, Gillian; Hammond, Emma; ... Rauch, Andri 2010
add to browser selection
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy Kaufmann, G. R.; Furrer, Hansjakob; Ledergerber, Bruno; Perrin, Luc; ... Battegay, Manuel 2005
add to browser selection
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) Opravil, Milos; Ledergerber, Bruno; Furrer, Hansjakob; Hirschel, Bernard; ... Weber, Rainer 2002
add to browser selection
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study Ledergerber, Bruno; Egger, M.; Opravil, M.; Telenti, A.; ... Weber, R. 1999
add to browser selection
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study Greub, Gilbert; Ledergerber, Bruno; Battegay, M.; Grob, P.; ... Telenti, A. 2000
add to browser selection
Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study Hasse, Barbara; Walker, A Sarah; Fehr, Jan; Furrer, Hansjakob; ... Ledergerber, Bruno 2014
add to browser selection
Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy Arnedo, Mireia; Taffe, Patrick; Sahli, Roland; Furrer, Hansjakob; ... Tarr, P. E. 2007
add to browser selection
Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study Rotger, Margalida; Bayard, Cornelia; Taffe, Patrick; Martinez, Raquel; ... Tarr, P. E. 2009
add to browser selection
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study Glass, T. R.; De Geest, Sabina; Weber, Rainer; Vernazza, P. L.; ... Bucher, H. C. 2006
add to browser selection
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study Furrer, Hansjakob; Egger, M.; Opravil, M.; Bernasconi, Enos; ... Malinverni, R. 1999
add to browser selection
Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure Rauch, Andri; James, Ian; Pfafferott, Katja; Nolan, David; ... Gaudieri, Silvana 2009
add to browser selection
Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir Karrer, Urs; Ledergerber, Bruno; Furrer, Hansjakob; Elzi, Luigia; ... Speck, R. F. 2005
add to browser selection
Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study Vo, Thi Tuyet Nhung; Ledergerber, Bruno; Keiser, Olivia; Hirschel, Bernard; ... Weber, Rainer 2008
add to browser selection
Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study Glass, T. R.; Weber, Rainer; Vernazza, P. L.; Rickenbach, Martin; ... Bucher, H. C. 2007
add to browser selection
Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis Fenner, Lukas; Egger, Matthias; Bodmer, Thomas; Altpeter, Ekkehardt; ... Gagneux, Sebastien 2012
add to browser selection
Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study Zinkernagel, A. S.; von Wyl, Viktor; Ledergerber, Bruno; Rickenbach, Martin; ... Weber, Rainer 2006
add to browser selection
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis Scherrer, Alexandra U; von Wyl, Viktor; Yang, Wan-Lin; Kouyos, Roger D; ... Günthard, Huldrych F 2016
add to browser selection
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types von Wyl, Viktor; Yerly Ferrillo, Sabine; Boni, Jurg; Burgisser, Philippe; ... Gunthard, Huldrych 2007
add to browser selection
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir von Wyl, Viktor; Yerly Ferrillo, Sabine; Böni, Jürg; Bürgisser, Philippe; ... Günthard, Huldrych F. 2008
add to browser selection
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study Ledergerber, Bruno; Furrer, Hansjakob; Rickenbach, Martin; Lehmann, Roger; ... Weber, Rainer 2007
add to browser selection
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial Ananworanich, Jintanat; Nuesch, Reto; Le Braz, Michelle; Chetchotisakd, Ploechan; ... Yerly Ferrillo, Sabine 2003
add to browser selection
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study Rauch, Andri; Kutalik, Zoltan; Descombes, Patrick; Cai, Tao; ... Bochud, Pierre-Yves 2010
add to browser selection
Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland Shilaih, Mohaned; Marzel, Alex; Yang, Wan Lin; Scherrer, Alexandra U; ... Kouyos, Roger 2016
add to browser selection
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy Sterne, J. A.; May, M.; Bucher, H. C.; Ledergerber, Bruno; ... Egger, M. 2007
add to browser selection
Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study Wandeler, Gilles; Gsponer, Thomas; Bihl, Florian; Bernasconi, Enos; ... Rauch, Andri 2013
add to browser selection
Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic Wandeler, Gilles; Gsponer, Thomas; Bregenzer, Andrea; Günthard, Huldrych F; ... Rauch, Andri 2012
add to browser selection
Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions Salazar-Vizcaya, Luisa; Kouyos, Roger D; Zahnd, Cindy; Wandeler, Gilles; ... Rauch, Andri 2016
add to browser selection
Hepatitis delta-associated mortality in HIV/HBV-coinfected patients Beguelin, Charles; Moradpour, Darius; Sahli, Roland; Suter-Riniker, Franziska; ... Wandeler, Gilles 2017
add to browser selection
Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy Young, Jim; Glass, T. R.; Bernasconi, Enos; Rickenbach, Martin; ... Bucher, H. C. 2009
add to browser selection
HIV and solid organ transplantation: the Swiss experience Muller, N. J.; Furrer, Hansjakob; Kaiser, Laurent; Hirschel, Bernard; ... Weber, Rainer 2006
add to browser selection
HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis Fenner, Lukas; Egger, Matthias; Bodmer, Thomas; Furrer, Hansjakob; ... Gagneux, Sebastien 2013
add to browser selection
HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss Schupbach, Jorg; Gunthard, Huldrych; Joos, Beda; Fischer, Marek; ... Hirschel, Bernard 2005
add to browser selection
HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy Rauch, Andri; Nolan, David; Furrer, Hansjakob; McKinnon, Elizabeth; ... James, Ian 2008
add to browser selection
How reliable is an undetectable viral load? Combescure, Christophe; Vallier, N.; Ledergerber, Bruno; Cavassini, M.; ... Hirschel, Bernard 2009
<< previous | 1 | 2 | 3 |